The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
iMYC: Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified oesophagogastric carcinoma.
 
Michael Davidson
No Relationships to Disclose
 
Irene Yu-Shing Chong
Research Funding - Janssen
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Lauren Aronson
No Relationships to Disclose
 
Hanna Bryant
No Relationships to Disclose
 
Ruwaida Begum
No Relationships to Disclose
 
John Swansbury
No Relationships to Disclose
 
Andrew Wotherspoon
Honoraria - Roche
Consulting or Advisory Role - Celgene
 
Nik Matthews
No Relationships to Disclose
 
Ye Mong To
No Relationships to Disclose
 
Eleftheria Kalaitzaki
No Relationships to Disclose
 
Lina Yuan
No Relationships to Disclose
 
David J. Watkins
No Relationships to Disclose
 
Naureen Starling
No Relationships to Disclose
 
Sheela Rao
No Relationships to Disclose
 
Ian Chau
Honoraria - Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Lilly; Macrogenics; MSD Oncology; Sanofi
Research Funding - Janssen-Cilag (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Merck Serono; MSD; Sanofi